ArticleBMC medical imaging2025
S index: a predictor comparable to ultrasound shear wave elastography in assessing liver fibrosis in patients with chronic hepatitis B.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Assessing Liver Fibrosis in Chronic Hepatitis B: Liver Biopsy or Non-Invasive Fibrosis Markers?Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundChronic hepatitis B poses a major global health challenge, especially in developing countries. It significantly contributes to morbidity and mortality from liver cirrhosis and hepatocellular carcinoma.
objectiveTo evaluate diagnostic performance of ultrasound shear wave elastography (USWE), S index, Z index, Fibrometer in continuous differentiation of liver fibrosis in a retrospective chronic hepatitis B patients' cohort. MATERIALS AND
methodsWe collected liver stiffness values measured by USWE and laboratory indicators from 146 patients with chronic hepatitis B at Baoji Central Hospital. Serum fibrosis models were calculated using formulas, including S index, Z index, and Fibrometer. Using liver biopsy pathology as a reference, the diagnostic efficacy of each indicator for liver fibrosis staging was evaluated using receiver operating characteristic curves (ROC).
resultsS index and USWE demonstrated comparable diagnostic accuracy for liver fibrosis staging with areas under ROC (AUCs) of 0.791 vs. 0.860 (p = 0.679) for significant fibrosis (S ≥ 2), 0.867 vs. 0.942 (p = 0.074) for severe fibrosis (S ≥ 3), and 0.961 vs. 0.932 (p = 0.508) for cirrhosis (S4). The two indices exhibited superior performance over Fibrometer across all stages (S index/USWE vs. Fibrometer-AUCs: 0.791/0.806 vs. 0.575, < 0.001 for S ≥ 2; 0.867/0.940 vs. 0.625, p < 0.001 for S ≥ 3; 0.961/0.932 vs. 0.781, p = 0.004/0.025 for S4). Compared with Z index, they showed better diagnostic capacity for S ≥ 2 (AUCs 0.791/0.806 vs. 0.575, p < 0.001) and S ≥ 3 (0.867/0.942 vs. 0.673, p < 0.001), while maintaining equivalent accuracy for cirrhosis detection (AUCs 0.961/0.932 vs. 0.914, p = 0.209/0.747).
conclusionThe S index is equally effective as the USWE in diagnosing liver fibrosis among patients with chronic hepatitis B, and it is superior to both the Z index and Fibrometer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.